This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
Zacks Industry Outlook Highlights Aflac, Unum Group Amerisafe, Employers Holdings and Trupanion
by Zacks Equity Research
Aflac, Unum Group Amerisafe, Employers Holdings and Trupanion are included in this blog.
5 Accident & Health Insurance Stocks to Watch as Exposure Rises
by Tanuka De
Higher claims frequency leading to upward pricing pressure, coupled with adoption of technology will boost performance of Zacks Accident and Health Insurance industry insurance players like AFL, UNM, TRUP, EIG and AMSF.
Trupanion (TRUP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 62.50% and 0.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Aflac (AFL) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of 2.40% and 4.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Trupanion (TRUP) Q4 Earnings Expected to Decline
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
East West Bancorp (EWBC) Misses Q4 Earnings Estimates
by Zacks Equity Research
East West Bancorp (EWBC) delivered earnings and revenue surprises of -1.94% and 1.85%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Here's Why You Should Stay Invested in Trupanion (TRUP)
by Zacks Equity Research
Trupanion (TRUP) is poised for growth in a total addressable market of $34.1 billion, given a change in the attitude of pet owners, who are increasingly focusing on pets' health and well-being.
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
Trupanion (TRUP) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 77.78% and 2.02%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
Trupanion (TRUP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Offing for Unum Group (UNM) in Q3 Earnings?
by Zacks Equity Research
Unum Group (UNM) Q3 is likely to benefit from better results at its Unum U.S and Colonial Life segments.
Why Should You Hold Onto the Pet Insurer Trupanion (TRUP)?
by Zacks Equity Research
Trupanion's (TRUP) long-term growth strategy and the burgeoning pet insurance market make it a stock to hold onto for netting solid long-term gains.
Trupanion (TRUP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 52.94% and 1.96%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Trupanion (TRUP) Q2 Earnings Expected to Decline
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Launches Pet Insurance Product, Boosts Portfolio
by Zacks Equity Research
MetLife (MET) introduces a pet insurance product, which intends to offer enhanced care for pets and address financial stress of pet parents.
Moving Average Crossover Alert: Trupanion (TRUP)
by Zacks Equity Research
Trupanion (TRUP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -25.00% and 1.91%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Aflac (AFL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Aflac's (AFL) first-quarter results are likely to reflect higher adjusted net investment income and cost-curbing efforts, partly offset by weaker sales.
Trupanion (TRUP) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -200.00% and 2.45%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Trupanion (TRUP) Q4 Earnings Expected to Decline
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -75.00% and 2.65%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?